MicroRNA-29b-3p reduces cisplatin resistance in non-small cell lung cancer by targeting myeloid cell leukemia-1
Article in Molecular & Cellular Toxicology (April 2024)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
MiRNA-Based Therapies for Lung Cancer: Opportunities and Challenges?
Article in Biomolecules (May 2023)
TRIM17-mediated ubiquitination and degradation of RBM38 promotes cisplatin resistance in non-small cell lung cancer
Article in Cellular Oncology (May 2023)